slotkoers
Taipei Exchange
00:00:00 27-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
26,45
TWD
|
+9,98%
|
|
+12,79%
|
+18,34%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
423,4
|
579,7
|
749,5
|
569,8
|
517,4
|
520,8
|
Bedrijfswaarde
1 |
281,7
|
431,7
|
597,5
|
370,1
|
351
|
478,1
|
K/w-verhouding
|
15
x
|
18,9
x
|
25,3
x
|
41,4
x
|
54,2
x
|
-197
x
|
Dividendrendement
|
6,17%
|
4,79%
|
3,04%
|
1,98%
|
0,81%
|
-
|
Marktkapitalisatie/omzet
|
1,1
x
|
1,39
x
|
1,88
x
|
1,82
x
|
1,61
x
|
1,86
x
|
Bedrijfswaarde/omzet
|
0,73
x
|
1,03
x
|
1,5
x
|
1,18
x
|
1,09
x
|
1,7
x
|
Bedrijfswaarde/EBITDA
|
6,08
x
|
9,41
x
|
14,1
x
|
16,7
x
|
14,4
x
|
50,4
x
|
Bedrijfswaarde/FCF
|
9,82
x
|
6,12
x
|
19,7
x
|
173
x
|
13,5
x
|
-27,8
x
|
FCF Yield
|
10,2%
|
16,3%
|
5,07%
|
0,58%
|
7,38%
|
-3,59%
|
Price to Book
|
1,72
x
|
2,31
x
|
2,97
x
|
1,84
x
|
1,7
x
|
1,78
x
|
Aantal aandelen (in duizenden)
|
20.704
|
20.704
|
20.704
|
23.304
|
23.304
|
23.304
|
Referentieprijs
2 |
20,45
|
28,00
|
36,20
|
24,45
|
22,20
|
22,35
|
Datum van publicatie
|
2/04/19
|
14/04/20
|
16/03/21
|
8/03/22
|
6/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
384,4
|
417,5
|
398,1
|
312,6
|
321,9
|
280,5
|
EBITDA
1 |
46,33
|
45,87
|
42,28
|
22,23
|
24,44
|
9,48
|
Bedrijfsresultaat (EBIT)
1 |
38,97
|
38,22
|
35,22
|
14,3
|
17,29
|
-4,259
|
Operationele Marge
|
10,14%
|
9,16%
|
8,85%
|
4,57%
|
5,37%
|
-1,52%
|
Resultaat voor belastingen (EBT)
1 |
37,14
|
39,85
|
37,14
|
16,6
|
13,55
|
-3,032
|
Nettowinst (verlies)
1 |
28,34
|
30,87
|
29,77
|
13,7
|
9,552
|
-2,648
|
Nettomarge
|
7,37%
|
7,39%
|
7,48%
|
4,38%
|
2,97%
|
-0,94%
|
WPA
2 |
1,360
|
1,480
|
1,430
|
0,5900
|
0,4099
|
-0,1136
|
Free Cash Flow
1 |
28,69
|
70,58
|
30,3
|
2,14
|
25,9
|
-17,18
|
FCF-marge
|
7,46%
|
16,91%
|
7,61%
|
0,68%
|
8,05%
|
-6,12%
|
Kasstroomconversie (ebitda)
|
61,93%
|
153,86%
|
71,66%
|
9,63%
|
106%
|
-
|
Kasstroomconversie (nettowinst)
|
101,24%
|
228,62%
|
101,76%
|
15,62%
|
271,17%
|
-
|
Dividend per aandeel
2 |
1,262
|
1,341
|
1,102
|
0,4844
|
0,1800
|
-
|
Datum van publicatie
|
2/04/19
|
14/04/20
|
16/03/21
|
8/03/22
|
6/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
142
|
148
|
152
|
200
|
166
|
42,8
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
28,7
|
70,6
|
30,3
|
2,14
|
25,9
|
-17,2
|
ROE (netto-inkomsten/eigen vermogen)
|
12,1%
|
12,4%
|
11,8%
|
4,87%
|
3,11%
|
-1,04%
|
ROA (netto-inkomsten/totale activa)
|
7,22%
|
6,09%
|
5,63%
|
2,28%
|
2,51%
|
-0,54%
|
Totale activa
1 |
392,3
|
507
|
529,2
|
601,6
|
380,3
|
489,5
|
Nettoactief per aandeel
2 |
11,90
|
12,10
|
12,20
|
13,30
|
13,00
|
12,50
|
Cashflow per aandeel
2 |
6,800
|
8,270
|
7,740
|
8,570
|
6,810
|
8,070
|
Capex
1 |
9,25
|
8,45
|
5,91
|
4,38
|
26,9
|
27,7
|
Capex/omzet
|
2,41%
|
2,02%
|
1,49%
|
1,4%
|
8,34%
|
9,89%
|
Datum van publicatie
|
2/04/19
|
14/04/20
|
16/03/21
|
8/03/22
|
6/03/23
|
14/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +18,34% | 17,19 mln. | | +21,85% | 46,93 mld. | | +37,63% | 39,08 mld. | | -8,05% | 38,48 mld. | | +29,04% | 31,01 mld. | | -13,75% | 26,14 mld. | | +10,65% | 25,88 mld. | | +38,43% | 12,53 mld. | | -6,92% | 11,36 mld. | | -12,29% | 10,65 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|